Fig. 5From: Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic effortsNumber of individuals with detectable HCV RNA across each pathway from 1999 to 2017 in Tayside with estimates of proportionate levels of HCV RNA positivity relative to total number of anti-HCV tests administered in each pathway. *Actively infected individuals as a proportion of all anti-HCV tests administered. Notes: Blue bars are number of actively infected individuals diagnosed in each pathway over the study period. Yellow dots are proportion of actively infected individuals relative to number of anti-HCV screening tests undertaken in that pathway in the study period. Numerous/denominators are as follows: primary care (n = 718/24,969); secondary care (n = 701/77,885); drug treatment services (n = 280/2415); pharmacies (n = 22/193); NSPs (n = 193/753); prisons (n = 428/2970); mosques (n = 6/177). Important: total diagnosed sums to 2348. This is all individuals including those who may have migrated from Tayside, been transiting through local prisons, or become otherwise ineligible for onward treatment locally. Abbreviations: NSPs, needle and syringe provision sitesBack to article page